GB
Highly rated in
19
conditions
Highly rated in
19
conditions
Check Dr. Gennady Bratslavsky's experience treating your condition:
About Dr. Gennady Bratslavsky

Gennady Bratslavsky is an Urologist and a Surgical Oncologist in Syracuse, New York. Bratslavsky has been practicing medicine for over 23 years and is highly rated in 19 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Pheochromocytoma, Prostate Cancer, Prostatectomy, and Endoscopy. He is licensed to treat patients in New York, Pennsylvania, and Virginia.

His clinical research consists of co-authoring 175 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gennady Bratslavsky it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
550 Harrison St, Suite N, Syracuse, NY 13202
Other Locations
4900 Broad Rd, Syracuse, NY 13215
267 Hill Rd, Rome, NY 13440
Background & Education
Graduate Institution
Albany Medical College Of Union University, 2000
Specialties
Urology
Surgical Oncology
Licenses
Urology in PA
Hospital Affiliations
UHS Binghamton General Hospital
Oneida Health Hospital
Auburn Community Hospital
Our Lady Of Lourdes Memorial Hospital
Upstate University Hospital - Downtown Campus
Cayuga Medical Center
Upstate University Hospital - Community Campus
Samaritan Medical Center
Lehigh Valley Hospital - Pocono
Oswego Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
View 2 Less Clinical Trial -

175 Total Publications

In Vivo Models for Prostate Cancer Research.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors